Skip to content
Press Release

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million

Sep. 13, 2023 by SOMAÍ

SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFARMED. This authorisation permits the Company to manufacture, import, and export medicinal cannabis products to numerous global markets and represents a significant step for the Company towards revenue generation. The Company also announces that it has successfully raised €5 million of new capital to fund its ambitious growth plans.